Global Molecular Diagnostics in Infectious Disease Testing Market Size, Status and Forecast 2021-2027

Global Molecular Diagnostics in Infectious Disease Testing Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.2.4 Microarrays
1.2.5 Next-Generation Sequencing (NGS)
1.2.6 Hybridization
1.2.7 Others
1.3 Market by Application
1.3.1 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academic Institutes
1.3.5 Laboratories
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Perspective (2016-2027)
2.2 Molecular Diagnostics in Infectious Disease Testing Growth Trends by Regions
2.2.1 Molecular Diagnostics in Infectious Disease Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Molecular Diagnostics in Infectious Disease Testing Historic Market Share by Regions (2016-2021)
2.2.3 Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Regions (2022-2027)
2.3 Molecular Diagnostics in Infectious Disease Testing Industry Dynamic
2.3.1 Molecular Diagnostics in Infectious Disease Testing Market Trends
2.3.2 Molecular Diagnostics in Infectious Disease Testing Market Drivers
2.3.3 Molecular Diagnostics in Infectious Disease Testing Market Challenges
2.3.4 Molecular Diagnostics in Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue
3.1.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue (2016-2021)
3.1.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Players (2016-2021)
3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics in Infectious Disease Testing Revenue
3.4 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics in Infectious Disease Testing Revenue in 2020
3.5 Molecular Diagnostics in Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Type
4.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Type (2016-2021)
4.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2022-2027)
5 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Application
5.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Application (2016-2021)
5.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size (2016-2027)
6.2 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type
6.2.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021)
6.2.2 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027)
6.2.3 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2027)
6.3 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application
6.3.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021)
6.3.2 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027)
6.3.3 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2027)
6.4 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country
6.4.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021)
6.4.2 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size (2016-2027)
7.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type
7.2.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021)
7.2.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027)
7.2.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2027)
7.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application
7.3.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021)
7.3.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027)
7.3.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2027)
7.4 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country
7.4.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021)
7.4.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size (2016-2027)
8.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type
8.2.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application
8.3.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region
8.4.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size (2016-2027)
9.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type
9.2.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021)
9.2.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027)
9.2.3 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2027)
9.3 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application
9.3.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021)
9.3.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027)
9.3.3 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2027)
9.4 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country
9.4.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021)
9.4.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size (2016-2027)
10.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type
10.2.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application
10.3.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country
10.4.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Introduction
11.1.4 Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics in Infectious Disease Testing Introduction
11.2.4 BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.2.5 BD Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Details
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Introduction
11.3.4 BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.3.5 BioMerieux Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Introduction
11.5.4 Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Siemens
11.6.1 Siemens Company Details
11.6.2 Siemens Business Overview
11.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Introduction
11.6.4 Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.6.5 Siemens Recent Development
11.7 Veridex
11.7.1 Veridex Company Details
11.7.2 Veridex Business Overview
11.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Introduction
11.7.4 Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.7.5 Veridex Recent Development
11.8 Luminex
11.8.1 Luminex Company Details
11.8.2 Luminex Business Overview
11.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Introduction
11.8.4 Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.8.5 Luminex Recent Development
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Details
11.9.2 GenMark Diagnostics Business Overview
11.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Introduction
11.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.9.5 GenMark Diagnostics Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Introduction
11.10.4 Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.10.5 Qiagen Recent Development
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Details
11.11.2 Genomix Biotech Business Overview
11.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Introduction
11.11.4 Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.11.5 Genomix Biotech Recent Development
11.12 BioTheranostics
11.12.1 BioTheranostics Company Details
11.12.2 BioTheranostics Business Overview
11.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Introduction
11.12.4 BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021)
11.12.5 BioTheranostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT)
Table 4. Key Players of Microarrays
Table 5. Key Players of Next-Generation Sequencing (NGS)
Table 6. Key Players of Hybridization
Table 7. Key Players of Others
Table 8. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions (2016-2021)
Table 12. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions (2022-2027)
Table 14. Molecular Diagnostics in Infectious Disease Testing Market Trends
Table 15. Molecular Diagnostics in Infectious Disease Testing Market Drivers
Table 16. Molecular Diagnostics in Infectious Disease Testing Market Challenges
Table 17. Molecular Diagnostics in Infectious Disease Testing Market Restraints
Table 18. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players (2016-2021)
Table 20. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2020)
Table 21. Ranking of Global Top Molecular Diagnostics in Infectious Disease Testing Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
Table 25. Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2016-2021)
Table 29. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Molecular Diagnostics in Infectious Disease Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2016-2021)
Table 33. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 65. Abbott Company Details
Table 66. Abbott Business Overview
Table 67. Abbott Molecular Diagnostics in Infectious Disease Testing Product
Table 68. Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 69. Abbott Recent Development
Table 70. BD Company Details
Table 71. BD Business Overview
Table 72. BD Molecular Diagnostics in Infectious Disease Testing Product
Table 73. BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 74. BD Recent Development
Table 75. BioMerieux Company Details
Table 76. BioMerieux Business Overview
Table 77. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product
Table 78. BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 79. BioMerieux Recent Development
Table 80. Thermo Fisher Scientific Company Details
Table 81. Thermo Fisher Scientific Business Overview
Table 82. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product
Table 83. Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 84. Thermo Fisher Scientific Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Molecular Diagnostics in Infectious Disease Testing Product
Table 88. Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 89. Roche Recent Development
Table 90. Siemens Company Details
Table 91. Siemens Business Overview
Table 92. Siemens Molecular Diagnostics in Infectious Disease Testing Product
Table 93. Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 94. Siemens Recent Development
Table 95. Veridex Company Details
Table 96. Veridex Business Overview
Table 97. Veridex Molecular Diagnostics in Infectious Disease Testing Product
Table 98. Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 99. Veridex Recent Development
Table 100. Luminex Company Details
Table 101. Luminex Business Overview
Table 102. Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 103. Luminex Recent Development
Table 104. GenMark Diagnostics Company Details
Table 105. GenMark Diagnostics Business Overview
Table 106. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product
Table 107. GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 108. GenMark Diagnostics Recent Development
Table 109. Qiagen Company Details
Table 110. Qiagen Business Overview
Table 111. Qiagen Molecular Diagnostics in Infectious Disease Testing Product
Table 112. Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 113. Qiagen Recent Development
Table 114. Genomix Biotech Company Details
Table 115. Genomix Biotech Business Overview
Table 116. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product
Table 117. Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 118. Genomix Biotech Recent Development
Table 119. BioTheranostics Company Details
Table 120. BioTheranostics Business Overview
Table 121. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product
Table 122. BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 123. BioTheranostics Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Type: 2020 VS 2027
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Isothermal Nucleic Acid Amplification Technology (INAAT) Features
Figure 4. Microarrays Features
Figure 5. Next-Generation Sequencing (NGS) Features
Figure 6. Hybridization Features
Figure 7. Others Features
Figure 8. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Academic Institutes Case Studies
Figure 12. Laboratories Case Studies
Figure 13. Others Case Studies
Figure 14. Molecular Diagnostics in Infectious Disease Testing Report Years Considered
Figure 15. Global Molecular Diagnostics in Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Molecular Diagnostics in Infectious Disease Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions: 2020 VS 2027
Figure 18. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions (2022-2027)
Figure 19. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players in 2020
Figure 20. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue in 2020
Figure 22. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2016-2021)
Figure 23. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2022-2027)
Figure 24. North America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2016-2027)
Figure 26. North America Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2016-2027)
Figure 27. North America Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2016-2027)
Figure 28. United States Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2016-2027)
Figure 32. Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2016-2027)
Figure 33. Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2016-2027)
Figure 34. Germany Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2016-2027)
Figure 44. China Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2016-2027)
Figure 52. Latin America Molecular Diagnostics in Infectious Disease Testing Market Share by Application (20

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Molecular Diagnostics Collaboration and Licensing Deals 2016-2023

Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 400

Molecular Diagnostics Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the molecular diagnostics deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of molecular diagnostics deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics deals. These deals tend to be multicomponent, s......

Global Molecular Diagnostic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 31-Oct-2023        Price: US 3380 Onwards        Pages: 120

Market Overview of Global Molecular Diagnostic market: According to our latest research, the global Molecular Diagnostic market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostic market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Molecular D......

Global Core Clinical Molecular Diagnostics Market (2023 Edition): Analysis By Technology (ISH, PCR, Sequencing, Others), By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Others), By Region, By Country: Market Insights and Forecast (2019-2029)

Published: 01-Oct-2023        Price: US 2450 Onwards        Pages: 220

Executive Summary Azoth Analytics has released a research report titled "Global Core Clinical Molecular Diagnostics Market (2023 Edition)" which provides a complete analysis of the Global Core Clinical Molecular Diagnostics industry in terms of market segmentation By Technology (In situ hybridization, Polymerase Chain Reaction, Sequencing, Others) and By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Other Applications) for the historical p......

Global Molecular Diagnostics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Sep-2023        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Molecular Diagnostics market: According to our latest research, the global Molecular Diagnostics market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Molecular diagnosis refers to applying molecular biology methods to detect changes in the structure or expression level of genet......

Global Molecular Diagnostics in Infectious Disease Testing Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 31-Aug-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Molecular Diagnostics in Infectious Disease Testing market: According to our latest research, the global Molecular Diagnostics in Infectious Disease Testing market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostics in Infectious Disease Testing market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time spa......

Global Molecular Diagnostics Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 114

Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as quantitative PCR systems. These systems monitor the amplification of the targeted DNA molecule during the exponential phase. The commonly used detection methods in these systems include fluorescent dyes and sequence specific DNA probes. Market Analysis and Insights: Global Molecular Diagnost......

Global Molecular Diagnostics Market 2023

Published: 13-Aug-2023        Price: US 2450 Onwards        Pages: 89

Description According to the latest data, the market size of the global satellite imaging for agriculture sector is expected to rise by USD 234.5 million with a CAGR of 6.26% by the end of 2029. The implementation of satellite imaging in agriculture involves utilizing satellites to capture high-resolution images of agricultural land. These images offer valuable data and insights that can be leveraged to improve agricultural systems and enhance farming practices. One of the key......

Global Molecular Diagnostics in Infectious Disease Testing Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 22-Jun-2023        Price: US 3260 Onwards        Pages: 129

The Molecular Diagnostics in Infectious Disease Testing market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Molecular Diagnostics in Infectious Disease Testing industry, and breaks down according to the type, application, and consumption area of Molecular Diagnostics in Infectious Disease Testing. The report also introduces pla......

Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Instruments, Software), Application (Respiratory Diseases, HAIs, Cancer, STDs, Hepatitis), Technology (RT-PCR, INAAT), End User (Clinics, Hospitals, ICUs) & Region - Global Forecast to 2028

Published: 14-Jun-2023        Price: US 4950 Onwards        Pages: 212

“Increasing prevalence of infectious diseases and cancer and the rising funding for R&D are driving the overall growth of the point-of-care molecular diagnostics market” The global point-of-care molecular diagnostics market size is projected to reach USD 3.4 billion by 2028 from USD 2.0 billion in 2023, at a CAGR of 10.6% during the forecast period. Market growth is driven by factors such as the increasing prevalence of infectious dise......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs